Isobuscaline
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Isobuscaline (IB), also known as 4-isobutoxy-3,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and scaline families related to mescaline.[1][2] It is the analogue and skeletal isomer of buscaline in which there is an isobutoxy group instead of a butoxy group at the 4 position.[1][2] The drug's dose range is 60 to 100 mg orally and its duration is 8 to 14 hours.[1] Its effects included little in the way of psychedelic visuals, no enhanced fantasy, and body load.[1] The chemical synthesis of isobuscaline has been described.[2] The drug was described in the scientific literature by Daniel Trachsel in 2002.[2] It is not a controlled substance in Canada as of 2025.[3]
- None
| Clinical data | |
|---|---|
| Other names | 4-Isobutoxy-3,5-dimethoxyphenethylamine; 3,5-Dimethoxy-4-isobutoxyphenethylamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 8–14 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C14H23NO3 |
| Molar mass | 253.342 g·mol−1 |
| 3D model (JSmol) | |
| |
| |